DEA Restricts Imports and Exports of Three Synthetic Substances
The Drug Enforcement Administration has issued a final order that, effective Nov. 15, temporarily places the following three synthetic phenethylamines into Schedule I of the Controlled Substances Act.
- 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; Cimbi-5)
- 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82)
- 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36)
This order imposes the administrative, civil and criminal sanctions and regulatory controls applicable to Schedule I substances under the CSA on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct institutional activities and possess) or propose to handle these substances. This order will remain in effect for two years and could be extended one additional year.
According to the DEA, these substances were developed over the last decade for use in mapping and investigating the serotonin receptors in the mammalian brain. However, published studies and law enforcement reports document that these substances are being abused in various ways and are purported to be hallucinogens. U.S. Customs and Border Protection data reveal that bulk quantities of these substances in powdered form have been seized from shipments originating overseas, particularly in Asia.